BC
ZYME icon

Brookfield Corp’s Zymeworks ZYME Stock Holding History

Brookfield Corp’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-63,032
Closed -$545K – 541
2023
Q2 		$545K Buy
+63,032
New +$564K ﹤0.01% 498
2023
Q1 		– Sell
-741,186
Closed -$5.83M – 802
2022
Q4 		$5.83M Buy
741,186
+537,534
+264% +$3.78M 0.02% 235
2022
Q3 		$1.25M Buy
203,652
+51,218
+34% +$309K ﹤0.01% 512
2022
Q2 		$808K Buy
152,434
+25,304
+20% +$153K ﹤0.01% 521
2022
Q1 		$833K Buy
+127,130
New +$1.13M ﹤0.01% 520

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Brookfield Corp's ZYME Position: Q3 2023 in Review

Brookfield Corp sold out of Zymeworks (ZYME) in Q3 2023, closing a stake of 63,032 shares — an estimated $545K sold.

Brookfield Corp first reported a position in ZYME in Q1 2022 and held it in 5 quarters. The position peaked at $5.83M in Q4 2022. 139 funds tracked by Wall St. Rank hold ZYME as of Q3 2023.

  • Brookfield Corp reported no remaining Zymeworks position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 63,032 Zymeworks shares in Q3 2023, an estimated $545K.
  • Brookfield Corp first reported a position in Zymeworks in Q1 2022 and held it in 5 quarters.
  • Brookfield Corp's Zymeworks position peaked at $5.83M in Q4 2022.
  • 139 funds tracked by Wall St. Rank held Zymeworks as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.